Because nations track IVF data by "cycles per million people" and "percentage of live births" rather than the flat percentage of all living women, here is how the two countries compare:

1. Access and Affordability

* Israel (100% Access): Israel offers the greatest per-capita access to IVF in the world. It is the only country that fully subsidizes unlimited IVF cycles through its national healthcare system. Any female citizen up to age 45 is eligible for state-funded IVF until she has up to two children with her current partner—regardless of her marital status or sexual orientation.

* United States (~25% Access): Access in the US is heavily restricted by income and insurance. A single IVF cycle often costs between $12,000 and $15,000+ out-of-pocket, and insurance mandates vary wildly by state. The American Society for Reproductive Medicine estimates that only 1 in 4 (25%) of infertile couples in the US can actually access and afford the fertility assistance they need.

2. Utilization and Outcomes

Because of this financial barrier, Israeli women consume IVF at a drastically higher rate than American women.

| Metric | Israel | United States |

|---|---|---|

| Annual IVF Cycles | ~5,000 to 5,700 per million people | ~1,200 per million people |

| Births Resulting from IVF | 4.5% to 5.8% of all births | 2% to 2.3% of all births |

(Note: US cycle estimates are based on the latest CDC data showing roughly 413,000 ART cycles initiated in 2021 for a population of ~330 million. Israel's rates have historically hovered above 5,000 per million, more than quadruple the US rate.)

Why is the gap so large?

Beyond the financial differences, Israel is a highly pronatalist society. Demographic competition, religious directives (the biblical commandment to "be fruitful and multiply"), and historical memory all drive a powerful cultural imperative to have children. While the US treats IVF largely as a private, elective medical service, Israel views subsidized reproduction as a fundamental right and a matter of national policy.

When comparing IVF between Israel and the United States, a fascinating paradox emerges: Israel has over five times the per capita access to IVF, but the United States reports a significantly higher success rate per individual cycle.

Here is the breakdown of the numbers and the cultural and financial reasons behind them.

1. Per Capita Usage (The Access Gap)

Nations track IVF access by looking at the number of cycles performed per one million inhabitants.

* Israel: Israel is by far the world leader in IVF utilization, performing roughly 5,300 to 5,711 cycles per 1 million people annually.

* United States: Despite performing a massive total volume of cycles nationwide, the US lags far behind in per capita access, performing only 922 cycles per 1 million people.

(Israel performs over five times more IVF per capita than the US.)

2. Success Rates (Live Births per Cycle)

When tracking success, the standard medical metric is the live-birth rate per cycle—how many cycles actually result in a baby being born, rather than just a positive pregnancy test.

| Metric | Israel | United States |

|---|---|---|

| Average Live-Birth Rate (All Ages) | ~14.4% – 17.2% | 37.5% |

| Live-Birth Rate (Under 35) | Data blended into national avg | 42.8% |

| Live-Birth Rate (Over 40) | ~5.2% | 10.3% – 27.7% (drops steeply past age 42) |

(Note: US data reflects the 2022 CDC National ART Summary. Israeli data reflects historical Ministry of Health and Maccabi registry tracking.)

3. The Paradox: Why are US success rates higher?

It seems counterintuitive that the country with the best access has a lower per-cycle success rate, but it comes down to how the treatments are funded:

* The "Free vs. Out-of-Pocket" Filter: In the US, IVF is heavily privatized. Because of this immense financial burden, American patients and clinics are highly selective. If a woman has a very low statistical chance of success due to age or diminished ovarian reserve, she will often stop treatment early or switch to using donor eggs so she doesn't spend money on a cycle unlikely to succeed. This artificially inflates the US national success average.

* Unlimited Tries in Israel: In Israel, the national health basket fully funds practically unlimited IVF cycles up to age 45 for eligible patients. Because there is no financial penalty for trying again, Israeli women continue to undergo cycles well into their 40s. Even when the statistical chance of a live birth drops to around 5% for older patients, they keep trying because the state covers the cost.

The Bottom Line: While the US has a higher chance of success on a single attempt, the cumulative chance of a woman eventually having a child is exceptionally high in Israel because she can undergo multiple rounds of IVF without facing financial ruin.

(http://www.autoadmit.com/thread.php?thread_id=5892487&forum_id=2#50065058)

i think this is what matters: "the cumulative live birth rate of all patients undergoing oocyte warming was 28.9%"

(http://www.autoadmit.com/thread.php?thread_id=5892487&forum_id=2#50065233)

The fact is that if a woman in her mid 30s isn't *very* actively trying to get knocked up she never will. The type of woman that is still unsure but wants to keep her options open isn't likely to finally make such a major decision if she was uncertain at 29, 30, 31...

(http://www.autoadmit.com/thread.php?thread_id=5892487&forum_id=2#50065289)

Congrats on the kiddo!

(http://www.autoadmit.com/thread.php?thread_id=5892487&forum_id=2#50065436)